Characteristics of in vivo murine erythropoietic response to sodium orthovanadate

Chemico-Biological Interactions

Volumn 156, Issue 1, 2005, Pages 55-68

  Aguirre, María Victoria ^a   Juaristi, Julián Antonio ^a   Alvarez, Mirta Alba ^a   Brandan, Nora Cristina ^a  

^a UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

Author keywords

Antiapoptosis; Epo R; Erythropoiesis; GATA 1; Sodium orthovanadate

Indexed keywords

ERYTHROPOIETIN RECEPTOR; IRON 59; PROTEIN BCL XL; TRANSCRIPTION FACTOR GATA 1; VANADATE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; BLOOD; BLOOD FLOW; BONE MARROW; BONE MARROW CELL; BONE MARROW TOXICITY; BURST FORMING UNIT E; CELL COMPARTMENTALIZATION; CELL MATURATION; CELL SURVIVAL; CELL VIABILITY; CLONOGENIC ASSAY; COLONY FORMING UNIT E; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG RESPONSE; ERYTHROBLAST; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMATOPOIETIC TISSUE; IMMUNOBLOTTING; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RETICULOCYTE; SPLEEN; STEM CELL;

ANIMALS; BONE MARROW; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; HEMATOLOGIC TESTS; HEMATOPOIETIC STEM CELLS; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ERYTHROPOIETIN; RETICULOCYTES; TIME FACTORS; VANADATES;

MURINAE;

EID: 24944577055     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.07.003     Document Type: Article

References (63)

1. M.D. Waters Toxicity of vanadium R.A. Groger M.A. Mehlmann Advances in Modern Toxicology 2nd ed. 1977 Hemisphere Washington, DC 147 189
2. J.M. Liobet, and J.L. Domingo Acute toxicity of vanadium compounds in rats and mice Toxicol. Lett. 23 1984 227 231
3. A.M. Cortizo, S. Molinuelo, and S.B. Etcheverry A possible role of oxidative stress in the vanadium-induced citotoxicity in the MC3T3E1 osteoblast and UMR 106 osteosarcoma cell lines Toxicology 147 2000 89 99
4. M. Altamirano-Lozano Genotoxic effects of vanadium compounds Invest. Clin. 39 1998 39 47
5. D. Rehder Structure and function of vanadium compounds in living organisms BioMetals 5 1992 3 12
6. P. Poucheret, S. Verna, M.D. Grynpas, and J.H. Mc Neill Vanadium and diabetes Mol. Cell Biochem. 188 1998 73 80
7. D.C. Crans Chemistry and insulin-like properties of vanadium (IV) and vanadium (V) compounds J. Inorg. Biochem. 80 2000 123 131
8. M.C. Cam, R.W. Brownsey, and J.H. Mc Nelly Mechanisms of vanadium action: insulin-mimetic and insulin-enhancing agents? Can. J. Physiol. Pharmacol. 78 2000 829 847
9. L. Marzban, and J.H. Mc Neill Insulin-like actions of vanadium: potential as a therapeutic agent J. Trace Elements Exp. Med. 16 2003 253 267
10. P.M. Clarkson, and E.S. Rawson Nutritional supplements to increase muscle mass Crit. Rev. Food Sci. Nutr. 39 1999 317 328
11. A. Evangelou, S. Karkabounas, G. Kalpouzos, M. Malamas, R. Liasko, D. Stefanou, A.T. Vlahos, and T.A. Kabanos Comparison of the therapeutic effects of two vanadium complexes administered at low doses on benzo[a]pyrene-induced malignant tumors in rats Cancer Lett. 119 1997 221 225
12. 3 Biochem. Biophys. Acta 150 2000 273 282
13. C. Djorgevitz Antitumor activity of vanadium compounds H. Sigel A. Sigel Metal Ions in Biological Systems 1995 Marcel Dekker NY 596 616
14. E. Sabbioni, G. Pozzi, A. Pintar, L. Casella, and S. Garattini Cellular retention cytotoxicity and morphological transformation by vanadium (IV) and vanadium (V) in BALB/3T3 cell lines Carcinogenesis 12 1991 47 52
15. J.K. Klarlund, S. Latini, and J. Forchhammer Numerous proteins phosphorylated on tyrosine and enhanced tyrosine kinase activities in vanadate-treated NIH 3T3 fibroblasts Biochem. Biophys. Acta 971 1988 112 120
16. G. Huyer, S. Liu, J. Nelly, J. Moffat, P. Payette, B. Kennedy, G. Tsaprailis, M.J. Gresser, and C. Ramachandran Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate J. Biol. Chem. 272 1997 843 851
17. J.Y. Lau, K.P. Qian, P.C. Wu, and G.L. Davis Ribonucleotide vanadyl complexes inhibit polymerase chain reaction Nucl. Acid Res. 21 1993 2777
18. A. Davison, A. Stern, D. Fatur, and S.-S. Tsang Vanadate stimulated ornithine decarboxylase activity in C3H/10T1/2 cells Biochem. Int. 24 1991 461 466
19. A. Stern, X. Yin, S.-S. Tsang, A. Davison, and J. Moon Vanadium as a modulator of cellular regulatory cascades and oncogene expression Biochem. Cell Biol. 71 1993 103 112
20. M. Altamirano-Lozano, L. Alvarez-Barrera, F. Basurto-Alcántara, M. Valverde, and E. Rojas Reprotoxic and genotoxic studies of vanadium pentoxide in male mice Teratog. Carcinog. Mutag. 16 1996 7 17
21. J.B. Smith Vanadium ions stimulate DNA synthesis in Swiss 3T3 and 3T6 cells Proc. Natl. Acad. Sci. U.S.A. 80 1983 6162 6166
22. M. Ding, J.J. Li, S.S. Leonard, J.P. Ye, X. Shi, N.H. Colburn, V. Castranova, and V. Vallyathan Vanadate-induced activation of activator protein-1 role of reactive oxygen species Carcinogenesis 20 1999 663 668
23. J. Ye, M. Ding, X. Zhang, Y. Rojanasakul, S. Nedospasov, V. Vallyathan, V. Castranova, and X. Shi Induction of TNF alpha in macrophages by vanadate is dependent on activation of transcription factor NF-kappa B and free radical reactions Mol. Cell. Biochem. 198 1999 193 200
24. I. Jaspers, J.M. Samet, S. Erzurum, and W. Reed Vanadium induced kappa b dependent transcription depends upon peroxide-induced activation of the p38 mitogen-activated protein kinase Am. J. Respir. Cell. Mol. Biol. 23 2000 95 102
25. S.K. Pandey, J.F. Theberge, M. Bernier, and A.K. Srivastava Phosphatidylinositol-3 kinase requirement in activation of the ras/c-raf/MEK/ERK and p70 (s6k) signaling cascade by the insulinomimetic agent vanadylsulfate Biochemistry 38 1999 14667 14675
26. C. Huang, Z. Zhang, M. Ding, J. Li, J. Ye, S.S. Leonard, H.M. Shen, L. Butterworth, Y. Lu, M. Costa, Y. Rojanasakul, V. Castranova, V. Vallyathan, and X. Shi Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis J. Biol. Chem. 275 2000 32516 32522
27. J. Bungert, and D.J. Engle The role of transcriptional factors in erythroid development Ann. Med. 28 1996 47 55
28. Ch. Perry, and H. Soreq Transcriptional regulation of erythropoiesis Eur. J. Biochem. 269 2002 3607 3618
29. L expression Blood 94 1999 87 96
30. L.I. Zon, H. Youssoufian, C. Mather, H.F. Lodish, and S.H. Orkin Activation of the erythropoietin receptor promoter by transcription factor GATA-1 Proc. Natl. Acad. Sci. U.S.A. 88 1991 10638 10641
31. T. Sato, T. Maekawa, W. Sumiko, T. Kohichiro, and T. Nakahata Erythroid progenitors differentiate and mature in response to endogenous erythropoietin J. Clin. Invest. 106 2000 263 270
32. R. Kapur, and L. Zhang A novel mechanism of cooperation between c-kit and erythropoietin receptor J. Biol. Chem. 276 2001 1099 1106
33. L through STAT-5 in erythropoietin dependent progenitor cell lines J. Biol. Chem. 274 1999 22165 22169
34. H. Zaporowska, and W. Wasilewski Same selected peripheral blood and haematopoietic indices in Wistar rats with chronic vanadium intoxication Comp. Biochem. Physiol. 93 1989 175 180
35. S. Dai, E. Vera, and J.H. Mc Neill Lack of haematological effect of oral vanadium treatment in rats Pharmacol. Toxicol. 76 1995 263 268
36. G.R. Hogan Comparative erythropoietic effects of three vanadium compounds Sci. Total Environ. 256 2000 185 189
37. J.P. Fawcett, S.J. Farquhar, T. Thou, and B.I. Shand Oral vanadyl sulphate does not affect blood cells, viscosity or biochemistry in humans Pharmacol. Toxicol. 80 1997 202 206
38. C. Tolis, G.J. Peters, H.M. Pinedo, and G. Giaccone Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines Eur. J. Cancer 35 1999 796 807
39. J.F. Kerr, C.M. Winterford, and B.V. Harmon Apoptosis. Its significance in cancer and cancer therapy Cancer 73 1994 2013 2026
40. 32P labeled red cells Proc. Soc. Exp. Biol. Med. 1949 71 176
41. C.E. Bozzini, M.E. Barrio Rendo, F.C.H. Devoto, and C.E. Epper Studies on medullary and extramedullary erythropoiesis in the adult mouse Am. J. Physiol. 219 1970 724 728
42. M.M. Romero Benítez, M.V. Aguirre, J.A. Juaristi, M.A. Alvarez, J.M. Trifaró, and N.C. Brandan In vitro erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo-receptor expressions and apoptosis Toxicol. Appl. Pharmacol. 194 2004 230 238
43. R.G. Kendall Erythropoietin Clin. Lab. Haematol. 23 2001 71 80
44. M. Guo, and B.A. Hay Cell proliferation and apoptosis Curr. Opin. Cell Biol. 11 1999 745 752
45. M.J. Koury, S.T. Koury, P. Kopsombut, and M.C. Boundarant In vitro maturation of nascent reticulocytes to erythrocytes Blood 105 2005 2168 2174
46. G. Brecher, and F. Stohlman Jr. Reticulocyte size and erythropoietic stimulation Proc. Soc. Exp. Biol. Med. 107 1961 887 891
47. B.I. Lord Kinetics of the recognizable erythrocyte precursor cells Clin. Haematol. 8 1979 335 350
48. Y. Mishina, Y. Matsui, and M. Obinata Stage-specific gene expression in erythroid progenitor cells (CFU-E) Cell Diff. 3 1988 259 265
49. S.H. Boyer, K.T. Landschulz, and T.R. Bishop Patterns of differential gene expression during maturation of erythroid colony forming units Prog. Clin. Biol. Res. 251 1987 43 54
50. N. Suzuki, N. Suwabe, O. Onheda, N. Obara, S. Imagawa, X. Pan, H. Motohashi, and M. Yamamoto Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels Blood 102 2003 3575 3583
51. J. Cohen, H. Altaratz, Y. Zick, U. Klingmuller, and D. Neumann Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases Biochem. J. 327 1997 391 397
52. J.L. Spivak, J. Fisher, M.A. Isaacs, and W.D. Hankins Protein kinases and phosphatases are involved in erythropoietin mediated signal transduction Exp. Hematol. 20 1992 500 540
53. C.H. Dai, and S. Krantz Vanadate mimics the effect of the stem cell factor on highly purified human erythroid burst-colony forming units in vitro, but not the effect of Epo Exp. Hematol. 9 1992 1055 1060
54. P. Hulley, and A. Davison Regulation of tyrosine phosphorylation cascades by phosphatases: what the action of vanadium teaches us J. Trace Elements Exp. Med. 16 2003 281 290
55. J.H. Myklebust, H.K. Blomhoff, L.S. Rusten, T. Stokke, and E.B. Smeland Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34+ hematopoietic progenitor cells Exp. Hematol. 9 2002 990 1000
56. A.B. Goldfine, D.C. Simonson, F. Folli, M.-E. Patti, and C.R. Kahn Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies J. Clin. Endocrinol. Metab. 80 1995 3311 3320
57. S. Miyagawa, M. Kobayashi, N. Konishi, T. Sato, and K. Ueda Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors Br. J. Haematol. 109 2000 555 562
58. J.W. Fisher, and D.M. Gross Hormonal influences on erythropoiesis: anterior pituitary, adrenocortical, thyroid, growth and other hormones, in kidney hormones J.W. Fisher Erythropoietin vol. II 1977 Academic Press Inc. London Ltd. 415 435
59. V. Badmaev, S. Prakash, and M. Majeed Vanadium: a review of its potential role in the 'ht against diabetes J. Altern. Complem. Med. 5 1999 273 291
60. L.A. Malgor, C.C. Blanc, E. Klainer, S. Irizar, P.R. Torales, and L. Barrios Direct effects of thyroid hormones on bone marrow erythroid cells of rats Blood 45 1975 671 679
61. M. Motoyama, T. Kimura, T. Takahashi, T. Wanatabe, and T. Nakano Bcl-xL prevents antiapoptotic cell death of both primitive and definitive erythrocytes at the end of maturation J. Exp. Med. 189 1999 1691 1698
62. A.L. Lawson, H. Bao, A. Wickrema, S.M. Jacobs-Helber, and S.T. Sawyer Phosphatase inhibition promotes antiapoptotic but not proliferative signaling pathways in erythropoietin-dependent HCD 57 cells Blood 96 2000 2084 2092
63. G. De Haan, B. Dontje, and W. Nijhof Concepts of hemopoietic cell amplification. Synergy, redundancy and pleiotropy of cytokines affecting the regulation of erythropoiesis Leuk. Lymph. 22 1996 385 394